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lated through left brachial artery, and the
authors mentioned that they performed the
operation without circulatory arrest. Prefer-
ring the left brachial artery instead of right
for cannulation site may limit the use of
open distal repair technique when neces-
sary. Our group has reported 104 cases of
arch repair using right brachial artery
where open distal repair was easily per-
formed by reducing the flow and applying
atraumatic vascular clamps to the innomi-
nate and left carotid arteries.2
The authors have reported using 20F
cannulas during their two operations. Ac-
cording to our experience, a 20F cannula is
too large for the great majority of patients.
We preferred using the Calmed non–wire
reinforced venous return catheter (Califor-
nia Medical Laboratories, Irvine, Calif),
the tip of which can be trimmed to 16F to
18F diameter according to the size of the
patients’ brachial artery due to its conical
shape.
The authors suggest that the end of the
inserted cannula should not extend beyond
the origin of the subscapular artery to pro-
tect collateral circulation of the upper limb.
We inserted the catheter into the brachial
artery as its tip is positioned 5 to 7 cm
proximal to the arteriotomy, which in most
cases extended beyond the origin of the
subscapular artery, but this did not cause
upper limb ischemia in any of our patients.
We are in complete agreement with the
authors that the brachial artery is an easily
accessible site for cannulation. In our cur-
rent practice it is the standard for the repair
of aneurysms and dissections of the aortic
arch.
Seref A. Kucuker, MD
Oguz Tasdemir, MD
Department of Cardiovascular Surgery
Turkiye Yuksek Ihtisas Hospital
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Reply to the Editor:
We would like to thank Seref A. Ku¨cu¨ker
and Oguz Tasdemir for their comments on
our article. Unfortunately, when we sent
our material to the editorial office we were
not aware of their publication.1 The edito-
rial office of the Annals accepted their pub-
lication on February 7, 2002, while the
article sent by us arrived at the JTCS edi-
torial office on May 3 of the same year.
Our surgical team started the experi-
mental laboratory work for brachial artery
cannulation in 1999 for the purpose of en-
suring cardiopulmonary bypass and antero-
grade perfusion in the aortic arch, mainly in
the acute aortic dissection operations. This
was an interdisciplinary investigation car-
ried out jointly with the Applied and Clin-
ical Anatomical Laboratory, Department of
Anatomy, Histology, and Embriology,
from the Semmelweis University of
Budapest (this laboratory is led by Dr Lajos
Patonay); the clinical examinations were
performed in the Hand Microcirculation
Functional Laboratory from the Medical
and Health Science Center, University of
Debrecen (Dr Zolta´n Csiky and Dr Ildiko´
Garai). On the basis of the morphological
and hemodynamical laboratory investiga-
tion results, in 2001 it became possible for
us to ensure cardiopulmonary bypass just
through brachial artery cannulation.2
In our first patient we carried out left-
side brachial cannulation because in addi-
tion to the 2 femoral arteries, the right
subclavian artery was also effected
(namely, the pressure measured in the right
side brachial artery was 50 mm Hg lower).
In both cases we were able to use 20-F
cannulas with the technique described by
us (naturally this can vary between 16- and
20F-sized cannulas depending on the pa-
tient’s build).
It must be mentioned that during car-
diopulmonary bypass the pressures mea-
sured in the arterial line are higher, there-
fore we always endeavored to use the
thickest cannulas.
Despite there being no immediate clin-
ical consequences from not maintaining the
collateral circulation in the subscapular ar-
tery, on the basis of the above-mentioned
laboratory and clinical hand circulation ex-
aminations, we consider it important and
worthwhile to position the cannula such
that the collateral circulation through the
subscapular artery is maintained. It is pos-
sible that longer reperfusion under normo-
thermia could lead to temporary neurolog-
ical complications due to the reduced hand
perfusion.
Besides this, it is expedient to cannulate
the brachial artery as distally as possible, so
that the possible iatrogenic dissection
caused by the cannula remains at some
distance from the aortic arch. We are con-
vinced that the manufacturing companies,
jointly with the clinicians, will further de-
velop the manufacture of this kind of can-
nula.
Again, we thank Kucuker and Tasdemir
for their extremely interesting and valuable
work.
Zolta´n Galajda, MD, PhD
Istva´n Szentkira´lyi, MD
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Medical resources and capital
punishment
To the Editor:
The editorial in the March 2003 issue of the
Journal on heart transplantation for con-
victed felons1 made interesting reading.
McKneally and Sade agreed that human
life should be preserved without question.
A similar dilemma confronted me once,
when a prisoner awaiting death sentence
was brought in for a valve replacement
while his application for mercy was being
considered. Irrespective of his clinical sta-
tus, he would later be hanged to death. The
dilemma was whether we were doing the
right thing in replacing the valve so that he
could face his death sentence soon. Would
it have been preferable to reserve these
resources for someone whose death was
not so imminent? In any case, we replaced
his aortic valve. The patient is now alive 6
years after the operation, and his death
sentence has been commuted to life impris-
onment. He is brought for regular fol-
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low-up and has rehabilitated himself by
performing social work within the prison
walls. This case persuaded me to research
the law and resulted in a publication in the
Journal of Indian Law Institute.2 The sub-
ject was capital punishment and medical
science.
In the case referred to in the editorial, it
appears that medical professionals and le-
gal professionals can come together and
seek an alternative where valuable human
resource is not wasted in the hope of retri-
bution. I am referring to the large number
of prisoners waiting a death sentence in US
prisons. They could be potential organ do-
nors for the community. With the assis-
tance of the medical profession, each pris-
oner who is to be executed can provide
organs for 8 to 10 patients.
This would certainly appeal to society
at large. The article published in the Jour-
nal of Indian Law Institute2 has interested
the law commission in India, which is con-
sidering this suggestion. However, capital
punishment itself is rarely given out in In-
dian courts. Perhaps this thought may be
worth a closer look in your community,
where the number of convicts on death row
is large.
A. Sampath Kumar, MCh
Department of Cardiothoracic/Vascular
Surgery
All India Institute of Medical Sciences
New Delhi, India
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Reply to the Editor:
Readers will be grateful for the informative
letter from Dr Sampath Kumar, who raises
two interesting themes for ethical analysis.
The case that he reports shows how
changes in contextual details can clarify
values and illuminate moral reasoning de-
veloped from analysis of an index case, like
our heart transplant patient. This approach
to ethics is referred to as casuistry. In his
case, the patient was not just in prison but
was on death row, intensifying the apparent
strength of the argument from justice to
withhold treatment because of the serious-
ness of the crime. The treatment was an
expensive valve operation, although it did
not consume as scarce and as valuable a
resource as a donor heart. The principle
that guided his decision was that prisoners
are our fellow citizens and fellow human
beings, to whom physicians have a fidu-
ciary duty to provide care within the
boundaries of resource availability. It is
enriching that he can give us the outcome,
underlining the appropriateness of his de-
cision to apply this principle.
The second theme that he raises is the
issue of allowing prisoners to be organ
donors. The voluntary or involuntary re-
moval of vital organs after execution in
China is an efficient but potentially abusive
solution to the donor shortage. Clifford
Bartz, a federal inmate in Pennsylvania,
described the Inmate Organ Donor Net-
work in the March issue of the Kennedy
Institute of Ethics Journal.1 Bartz and his
colleagues propose that qualified inmates
who pledge up to three organs on their
death should be given 1 year of suspended
prison time, and those who serve as living
donors should receive 7 years of reduced
time. He describes several voluntary dona-
tions of organs from prisoners to their
needy relatives. These are examples of a
form of trade, trading time for organs. In
my Minnesota case of the prisoner who
wanted to collect “rent” for his donated
kidney, described in my reply to Dr Richen-
bacher’s letter,2 this proved to be a Faus-
tian bargain, but this single example should
not lead to a categorical ban. I recommend
a more empirical approach to test the opti-
mistic hypothesis that under the best cir-
cumstances, prisoner organ donation can
be an act of heroism leading to trust and
rehabilitation of a fallen comrade on the
road of life.
We need rewards for donation. As a
blood donor, I favor some advantage
within the health care system for those who
enrich it by donation. This might parallel
the airlines’ policy of rewarding frequent
flyers for their loyalty with expedited
boarding and free air travel on some under-
filled flights. Blood donors, and particu-
larly organ donors, deserve reasonable re-
wards within the health care system, as
long as they do not unfairly disadvantage
other patients. Such a reward system would
strengthen the value assigned by society to
the act or intention to donate.3 Finally, the
use of financial rewards should be explored
as even Veatch,4 a longtime opponent of
this policy, has grouchily come to accept.
The Council on Ethical and Judicial Affairs
of the American Medical Association,
stimulated no doubt by Bob Sade’s pres-
ence on the council, has recommended that
an empirical trial of financial rewards for
organ donors should be conducted to deter-
mine whether it will favorably or unfavor-
ably affect the overall rate of donation or
reduce the donor pool.5
Martin McKneally, MD, PhD
Department of Surgery
University of Toronto
Toronto, Ontario, Canada
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Bivalirudin as alternative to both
danaparoid and heparin in off-pump
coronary artery bypass grafting
To the Editor:
I enjoyed the recent article “Heparin Ver-
sus Danaparoid in Off-Pump Coronary By-
pass Grafting: Results of a Prospective
Randomized Clinical Trial” by Carrier and
colleagues.1 I favor off-pump coronary ar-
tery bypass grafting in patients with hepa-
rin-induced thrombocytopenia (HIT). Did
Carrier and colleagues1 consider using a
short-acting thrombin inhibitor such as
bivalirudin (Angiomax) rather than danap-
aroid as the heparin alternative?
I have used bivalirudin,2 a short-acting
thrombin inhibitor, in several patients with
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